Author

Danilo Ranaldi

Observed name: D Ranaldi

Observed institutions: Federico II University Hospital, University of Naples Federico II

OpenAlex ID: A5033686758

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

2009 · Antonio M. Risitano, Rosario Notaro, et al. · Blood · 369

Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study.

2015 · F Di Pierro, A Bressan, et al. · PubMed · 121

Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond.

2008 · Am Risitano, Guido Scalia, et al. · 8

C3-Mediated Extravascular Hemolysis as Additional Mechanism of Disease in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated by the Complent Inhibitor Eculizumab

2008 · Antonio M. Risitano, Ludovica Marando, et al. · Blood

Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond

2008 · Am Risitano, Ludovica Marando, et al.

Works count: 5

Citation count: 498

H-index: 3

I10-index: 2